IgG4 » Globe Newswire - TCN.VN

Nyxoah to Participate in Upcoming Investor Conferences 6-09-2023, 03:30

VCI Global Proposes To Acquire A 51% Stake In AI-Based Cogia GmbH 26-06-2023, 19:00

Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis 7-06-2024, 15:30

1-08-2023, 19:23

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

Globe Newswire1-08-2023, 19:23

Liên hệ quảng cáo

Hotline hỗ trợ quảng cáo: 0914.222.131
Email: quangcao@vietsoftgroup.com

Email: info@vietsoftgroup.com

© Copyright 2019 - Trang tin tức chuyên đề giới trẻ TCN News - Toàn bộ bài viết được chi sẻ bởi các thành viên.